BXRX
Baudax Bio, Inc.
Set alert
0.02 USD 0.00 0.00%
0.02 Day range 0.022025
0.0137 52-week range 3.47
- Open
- 0.0203
- Prev close
- 0.0218
- Mkt cap
- 0
- Vol
- 310.87K
- Avg vol
- 424.85K
- EPS
- -94.13
- P/E
- -0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.02
- High
- 0.022025
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 7, 2024
- 50-d avg
- 0.00
- 200-d avg
- 0.00
Financial health
Altman Z-Score
-15.90 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.0×
FY 2017 5y median -0.8× FY 2022
P/S 0.8×
FY 2017 5y median 0.8× FY 2022
P/B -0.0×
FY 2017 5y median -0.9× FY 2022
P/FCF -0.0×
FY 2017 5y median -0.4× FY 2022
EV/EBITDA -0.1×
FY 2017 5y median -0.1× FY 2022
EV/Sales 2.3×
FY 2017 5y median 0.0× FY 2022
FCF Yield -2637.5%
FY 2017 5y median -237.4% FY 2022
Profitability
Gross Margin -452.3%
FY 2017 5y median -126.4% FY 2022
Operating Margin -2816.6%
FY 2017 5y median -1759.8% FY 2022
Net Margin -4633.2%
FY 2017 5y median -1830.5% FY 2022
ROE 242.5%
FY 2017 5y median 107.8% FY 2022
ROIC 613.3%
FY 2017 5y median -47.7% FY 2022
ROA -586.1%
FY 2017 5y median -110.7% FY 2022
Growth (YoY)
Revenue 17.5%
FY 2017 FY 2022
Operating Income -88.1%
FY 2017 FY 2022
EPS (diluted) 50.9%
FY 2017 FY 2022
Free Cash Flow 43.8%
FY 2017 FY 2022
Financial Health
Current Ratio 0.3×
FY 2017 5y median 1.5× FY 2022
Quick Ratio 0.3×
FY 2017 5y median 1.2× FY 2022
Debt / Equity -0.3×
FY 2017 5y median -0.0× FY 2022
Net Debt / EBITDA -0.1×
FY 2017 5y median 0.0× FY 2022
Interest Coverage -1.7×
FY 2017 5y median -1.7× FY 2022
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31